Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.
Adam L. Halberstadt, Muhammad Chatha, Adam K. Klein, Jason Wallach, Simon D. Brandt
Neuropharmacology May 1, 2020 DOI: 10.1016/j.neuropharm.2019.107933 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Experimental study with dose-response experiments Peer reviewed |
|---|---|
| Population | C57BL/6J mice |
| Intervention | phenylalkylamine and tryptamine hallucinogens |
| Topics | DMT Mescaline Psilocybin |
| Keywords | Behavioral model Dom Head shake N,N-Dimethyltryptamine Nbome Psychedelic |
| Citations | 274 |
| Key findings | Potencies of hallucinogens in the mouse head-twitch response paradigm strongly correlate with their reported hallucinogenic potencies in humans and with drug discrimination ED50 values in rats. |
Abstract
Serotonergic hallucinogens such as lysergic acid diethylamide (LSD) induce head twitches in rodents via 5-HT2A receptor activation. The goal of the present investigation was to determine whether a correlation exists between the potency of hallucinogens in the mouse head-twitch response (HTR) paradigm and their reported potencies in other species, specifically rats and humans. Dose-response experiments were conducted with phenylalkylamine and tryptamine hallucinogens in C57BL/6J mice, enlarging the available pool of HTR potency data to 41 total compounds. For agents where human data are available (n = 36), a strong positive correlation (r = 0.9448) was found between HTR potencies in mice and reported hallucinogenic potencies in humans. HTR potencies were also found to be correlated with published drug discrimination ED50 values for substitution in rats trained with either LSD (r = 0.9484, n = 16) or 2,5-dimethoxy-4-methylamphetamine (r = 0.9564, n = 21). All three of these behavioral effects (HTR in mice, hallucinogen discriminative stimulus effects in rats, and psychedelic effects in humans) have been linked to 5-HT2A receptor activation. We present evidence that hallucinogens induce these three effects with remarkably consistent potencies. In addition to having high construct validity, the HTR assay also appears to show significant predictive validity, confirming its translational relevance for predicting subjective potency of hallucinogens in humans. These findings support the use of the HTR paradigm as a preclinical model of hallucinogen psychopharmacology and in structure-activity relationship studies of hallucinogens. Future investigations with a larger number of test agents will evaluate whether the HTR assay can be used to predict the hallucinogenic potency of 5-HT2A agonists in humans. "This article is part of the special issue entitled 'Serotonin Research: Crossing Scales and Boundaries'.
In the evidence
This study is part of the evidence base for 2 syntheses in the library. Here is how each one recorded it.
-
State of the evidence: DMT Supports
Hallucinogen potency in the mouse head-twitch response correlated strongly with reported human hallucinogenic potency (r = 0.9448, n = 36) and with rat drug-discrimination ED50 values.
Synthesized
-
State of the evidence: Mescaline Supports
Potencies of hallucinogens in the mouse head-twitch response paradigm strongly correlate with reported hallucinogenic potencies in humans and with drug discrimination ED50 values in rats.
Synthesized
Comparable studies
Other preclinical and animal studies on mescaline, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Brain mechanisms of hallucinogens and entactogens Humans and rats | 2001 | Review | |
| Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology Zebrafish (Danio rerio) | 2012 | Experimental study | |
| Lysergic Acid Diethylamide- and Mescaline-Induced Attenuation of the Effect of Punishment in the Rat Rats | 1976 | Experimental study | |
| Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups Rats (trained to discriminate saline from LSD tartrate) and rat cortical and... | 1996 | In vivo drug discrimination assay and in vitro radioligand binding assay | |
| Transient reinforcing effects of phenylisopropylamine and indolealkylamine hallucinogens in rhesus monkeys Rhesus monkeys with a history of MDMA self-administration | 2004 | Observational cohort | n = 4 |
Citations in the library
Cited by 237
- A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature 2021
- Psychedelics promote plasticity by directly binding to BDNF receptor TrkB Nature Neuroscience June 1, 2023
- Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice Proceedings of the National Academy of Sciences April 13, 2021
- Psychedelics reopen the social reward learning critical period Nature June 14, 2023
- The neural basis of psychedelic action. Nature Neuroscience October 24, 2022
and 232 more in the library
Cites 90
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
and 85 more in the library